Overview
Milagros Gordillo is a Nurse Practitioner practicing medicine in New York, New York.
Ms. Gordillo is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Pediatric Low-Grade Glioma (pLGG) and ALK-Positive Non-Small Cell Lung Cancer.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1275 York Ave Fl 18, New York, NY 10065
Weill Medical College Of Cornell
Karen Pekle is a Nurse Practitioner practicing medicine in New York, New York. Ms. Pekle is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Relapsed Refractory Multiple Myeloma (RRMM) and Smoldering Multiple Myeloma.
NY Office
David Mendoza is a Nurse Practitioner practicing medicine in New York, New York. Mr. Mendoza is highly rated in 1 condition, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer.
Office
Alison Hergianto is a Nurse Practitioner practicing medicine in New York, New York. Ms. Hergianto is highly rated in 1 condition, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer and Lung Nodules.
Frequently Asked Questions about Milagros Gordillo, NP
How do I make an appointment with Milagros Gordillo, NP?
You can book an appointment with Milagros Gordillo, NP by calling their office at 212-639-6920. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Milagros Gordillo, NP a top-rated expert for Pediatric Low-Grade Glioma (pLGG)?
MediFind is an objective health platform that identifies experts based on real-world data. Milagros Gordillo, NP is classified as an Advanced expert for Pediatric Low-Grade Glioma (pLGG), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Milagros Gordillo, NP specialize in?
While Milagros Gordillo, NP is a Nurse Practitioner, they have specific expertise in Pediatric Low-Grade Glioma (pLGG), ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nurse Practitioner.
Does Milagros Gordillo, NP accept my insurance?
Milagros Gordillo, NP accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-639-6920 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Pediatric Low-Grade Glioma (pLGG)Ms. Gordillo isAdvanced. Learn about Pediatric Low-Grade Glioma (pLGG).
- Experienced
- ALK-Positive Non-Small Cell Lung CancerMs. Gordillo isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.